NovMetaPharma Co., Ltd. (XKON:229500)

NovMetaPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2014	FY 2013
Period Ending	Feb 18, 2026	Dec 31, 2014	Dec 31, 2013
Net Debt / Equity Ratio	-0.66	-0.66	-0.64
Net Debt / EBITDA Ratio	46.49	46.49	-17.63
Net Debt / FCF Ratio	13.25	13.25	-8.57
Asset Turnover	0.33	0.33	-
Inventory Turnover	3.01	3.01	-
Quick Ratio	28.62	28.62	18.32
Current Ratio	32.26	32.26	26.50
Return on Equity (ROE)	10.84%	10.84%	-
Return on Assets (ROA)	-1.96%	-1.96%	-
Return on Capital Employed (ROCE)	-2.30%	-2.30%	2.10%
Buyback Yield / Dilution	-	-21.30%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.